Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Endometriosis gonadotropin-releasing hormone agonists

Tahara M, Matsuoka T, Yokoi T, Tasaka K, Kurachi H, Murata Y. Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin) a pilot study with low-dose agonist therapy ( draw-back therapy). Fertil SterU 2000 73(4) 799-804. [Pg.1534]

Trade names Profact Receptal Suprecor Suprecur (Sanofi-Aventis) Suprefact (Sanofi-Aventis) Suprefact Pro Suprefakt Indications Prostate cancer, endometriosis, uterine fibrosis. Category Gonadotropin-releasing hormone agonist Half-life 80 minutes... [Pg.83]

Trade names Prozoladex Zoladex (AstraZeneca) Indications Breast and prostate carcinoma, endometriosis Category Gonadotropin-releasing hormone agonist Half-life 5 hours... [Pg.269]

Vercellini P, Trespidi L, Colombo A, et al. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993 60 75-79. [Pg.1491]

Surrey ES. Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis Can a consensus be reached Add-Back Consensus Working Group. Fertil Steril 1999 71 420-424. [Pg.1491]

Intranasal Solutions Calcitonin for Paget s disease gonadotropin-releasing hormone (GnRH) agonist for management of endometriosis... [Pg.119]

Nafareiin acetate Solution Endometriosis/agonist of gonadotropin-releasing hormone Synarel ... [Pg.141]

See other pages where Endometriosis gonadotropin-releasing hormone agonists is mentioned: [Pg.1486]    [Pg.180]    [Pg.240]    [Pg.153]    [Pg.385]    [Pg.143]    [Pg.332]    [Pg.150]    [Pg.796]    [Pg.796]   


SEARCH



Endometriosis

Gonadotropin hormone

Gonadotropin release

Gonadotropin releasing

Gonadotropin-releasing hormone

Gonadotropin-releasing hormone agonists

Gonadotropin-releasing-hormon

Gonadotropins

Hormone release

© 2024 chempedia.info